Related Experiment Video

Updated: May 13, 2026

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

Studies on the contribution of c-fos/AP-1 to arthritic joint destruction

S Shiozawa1, K Shimizu, K Tanaka

  • 1Kobe University School of Medicine, Faculty of Health Science, Sumaku, Japan.

The Journal of Clinical Investigation
|March 15, 1997
PubMed

Insights

Researchers found that inhibiting the c-Fos/AP-1 signal can reduce rheumatoid joint destruction. Administering specific DNA oligonucleotides targeting AP-1 binding sites effectively halted joint damage in a mouse model of arthritis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Rheumatology

Background:

  • Rheumatoid arthritis involves synovial overgrowth and bone resorption.
  • These destructive features can be experimentally induced by increasing c-Fos gene expression.

Purpose of the Study:

  • To investigate if inhibiting the c-Fos/AP-1 signaling pathway can prevent joint destruction in collagen-induced arthritis.
  • To determine the efficacy and mechanism of AP-1 DNA oligonucleotides in a mouse model.

Main Methods:

  • Administered short double-stranded AP-1 DNA oligonucleotides to mice with collagen-induced arthritis.
  • Competed for AP-1 binding at promoter sites to inhibit gene expression.
  • Utilized immunohistochemical chase experiments to track oligonucleotide distribution.

Main Results:

  • Arthritic joint destruction was significantly inhibited in a sequence-specific and dose-dependent manner.
  • Oligonucleotides demonstrated inhibition of gene expression at the transcriptional level.
  • AP-1 oligonucleotides were successfully delivered to inflamed joints in arthritic mice.

Conclusions:

  • The c-Fos/AP-1 signaling pathway plays a crucial role in the pathogenesis of arthritic joint destruction.
  • AP-1 DNA oligonucleotides show therapeutic potential for inhibiting rheumatoid arthritis progression.
  • Targeting AP-1 offers a promising strategy for managing inflammatory joint diseases.

More Related Videos

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue09:18

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...